Mind Medicine (MindMed) Inc. financial data

Symbol
MNMD on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 526% % 0.17%
Debt-to-equity 38% % 13%
Return On Equity -86% % -63%
Return On Assets -62% % -57%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98,509,279 shares 34%
Common Stock, Shares, Outstanding 76,774,057 shares -5.9%
Entity Public Float $515,400,000 USD 268%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 85,885,516 shares 10%
Weighted Average Number of Shares Outstanding, Diluted 85,885,516 shares 7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $105,903,000 USD 92%
General and Administrative Expense $45,290,000 USD 17%
Operating Income (Loss) $151,193,000 USD -61%
Net Income (Loss) Attributable to Parent $168,098,000 USD -72%
Earnings Per Share, Basic -1 USD/shares 15%
Earnings Per Share, Diluted -1 USD/shares 33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $19,959,000 USD -93%
Assets, Current $215,848,000 USD -28%
Operating Lease, Right-of-Use Asset $600,000 USD
Goodwill $19,918,000 USD 0%
Other Assets, Noncurrent $1,150,000 USD 133%
Assets $236,916,000 USD -26%
Accounts Payable, Current $8,113,000 USD 278%
Accrued Liabilities, Current $19,028,000 USD 116%
Liabilities, Current $65,416,000 USD 97%
Other Liabilities, Noncurrent $519,000 USD
Liabilities $106,320,000 USD 85%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,001,000 USD 22%
Retained Earnings (Accumulated Deficit) $532,236,000 USD -46%
Stockholders' Equity Attributable to Parent $130,596,000 USD -50%
Liabilities and Equity $236,916,000 USD -26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $29,419,000 USD -77%
Net Cash Provided by (Used in) Financing Activities $1,002,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $162,458,000 USD
Common Stock, Shares, Issued 76,774,057 shares -5.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $190,887,000 USD -225%
Interest Paid, Excluding Capitalized Interest, Operating Activities $602,000 USD 39%
Deferred Tax Assets, Valuation Allowance $69,925,000 USD 37%
Operating Lease, Liability $600,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $167,918,000 USD -72%
Deferred Tax Assets, Operating Loss Carryforwards $42,466,000 USD 35%
Unrecognized Tax Benefits $0 USD
Operating Lease, Payments $900,000 USD
Amortization of Intangible Assets $0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance $0 USD -100%
Share-based Payment Arrangement, Expense $18,448,000 USD 13%
Interest Expense $4,870,000 USD 136%